Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with myocardial infarction (MI) seldom reach recommended targets for secondary prevention. This study evaluated a smartphone application ("app") aimed at improving treatment adherence and cardiovascular lifestyle in MI patients. DESIGN: Multicenter, randomized trial. METHODS: A total of 174 ticagrelor-treated MI patients were randomized to either an interactive patient support tool (active group) or a simplified tool (control group) in addition to usual post-MI care. Primary end point was a composite nonadherence score measuring patient-registered ticagrelor adherence, defined as a combination of adherence failure events (2 missed doses registered in 7-day cycles) and treatment gaps (4 consecutive missed doses). Secondary end points included change in cardiovascular risk factors, quality of life (European Quality of Life-5 Dimensions), and patient device satisfaction (System Usability Scale). RESULTS: Patient mean age was 58 years, 81% were men, and 21% were current smokers. At 6 months, greater patient-registered drug adherence was achieved in the active vs the control group (nonadherence score: 16.6 vs 22.8 [P = .025]). Numerically, the active group was associated with higher degree of smoking cessation, increased physical activity, and change in quality of life; however, this did not reach statistical significance. Patient satisfaction was significantly higher in the active vs the control group (system usability score: 87.3 vs 78.1 [P = .001]). CONCLUSIONS: In MI patients, use of an interactive patient support tool improved patient self-reported drug adherence and may be associated with a trend toward improved cardiovascular lifestyle changes and quality of life. Use of a disease-specific interactive patient support tool may be an appreciated, simple, and promising complement to standard secondary prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SUS: A 'Quick and Dirty' Usability Scale
(1996) · Usability Evaluation In Industry · doi:10.1201/9781498710411-35 · Cited by 8,989
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
Varnfield, M., Karunanithi, M., Lee, C.-K., Honeyman, E., Arnold, D., Ding, H., Smith, C., & Walters, D. L. (2014) · Heart · doi:10.1136/heartjnl-2014-305783 · Cited by 528
On the dimensionality of the System Usability Scale: a test of alternative measurement models
Borsci, S., Federici, S., & Lauriola, M. (2009) · Cognitive Processing · doi:10.1007/s10339-009-0268-9 · Cited by 275
Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes
Rieckmann, N., Gerin, W., Kronish, I. M., Burg, M. M., Chaplin, W. F., Kong, G., Lespérance, F., & Davidson, K. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.063 · Cited by 183
Bauer, L. K., Caro, M. A., Beach, S. R., Mastromauro, C. A., Lenihan, E., Januzzi, J. L., & Huffman, J. C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.12.017 · Cited by 162
Quilici, J., Fugon, L., Beguin, S., Morange, P. E., Bonnet, J.-L., Alessi, M.-C., Carrieri, P., & Cuisset, T. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.252 · Cited by 68
Cited by
Coorey, G. M., Neubeck, L., Mulley, J., & Redfern, J. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487317750913 · Cited by 281
Lunde, P., Nilsson, B. B., Bergland, A., Kværner, K. J., & Bye, A. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9751 · Cited by 214
“One study included both type 1 and type 2 DM [31], 1 study included patients with DM type 2 or CVD (ischemic heart disease and/or heart failure) [26], and 1 study included patients with myocardial infarction [32].”
BackgroundMethodInfluentialSanto, K., Singleton, A., Rogers, K., Thiagalingam, A., Chalmers, J., Chow, C. K., & Redfern, J. (2019) · Heart · doi:10.1136/heartjnl-2018-313479 · Cited by 112
Digital health intervention in acute myocardial infarction
Marvel, F. A., Spaulding, E. M., Lee, M. A., Yang, W. E., Demo, R., Ding, J., Wang, J., Xun, H., Shah, L. M., Weng, D., et al. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.007741 · Cited by 84
Leong, C. M., Lee, T.-I., Chien, Y.-M., Kuo, L.-N., Kuo, Y.-F., & Chen, H.-Y. (2022) · Journal of Medical Internet Research · doi:10.2196/31449 · Cited by 79
Metadata
- Authors
- Johnston, N., Bodegard, J., Jerström, S., Åkesson, J., Brorsson, H., Alfredsson, J., Albertsson, P. A., Karlsson, J.-E., & Varenhorst, C.
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 178
- Pages
- 85-94
- ISSN
- 0002-8703 (ISSN-L)
- OpenAlex
- W2395936517
- Cited by
- 172
- References
- 9
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.